Is HSDB 7461 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use HSDB 7461? Is HSDB 7461 safe for nursing mother and child? Does HSDB 7461 extracts into breast milk? Does HSDB 7461 has any long term or short term side effects on infants? Can HSDB 7461 influence milk supply or can HSDB 7461 decrease milk supply in lactating mothers?
HSDB 7461 lactation summary
- DrLact safety Score for HSDB 7461 is 7 out of 8 which is considered Dangerous as per our analyses.
- A safety Score of 7 indicates that usage of HSDB 7461 may cause toxic or severe side effects in breastfed baby.
- Our study of different scientific research indicates that HSDB 7461 may cause moderate to high side effects or may affect milk supply in lactating mother.
- Our suggestion is to use safer alternate options rather than using HSDB 7461 .
- Usage of HSDB 7461 is in contradiction to breastfeeding hence if it is must to use HSDB 7461 and there is no better alternative available then breastfeeding shall be stopped permanently or temporarily.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About HSDB 7461 usage in lactation
Drug is cleared from the body in 5 elimination half-lives. Resuming breastfeeding is likely safe after 10 days of pumping-and-dumping.
Answer by DrLact: About HSDB 7461 usage in lactation
No information is available on the use of HSDB 7461 during breastfeeding. The manufacturer recommends that breastfeeding be discontinued during HSDB 7461 therapy and for 3 weeks after the last dose.
Alternate Drugs
Cetuximab(Unsafe)
Mercaptopurine(Safe)
Carboplatin(Dangerous)
Hydroxyurea(Low Risk)
Gemcitabine(Dangerous)
Paclitaxel(Dangerous)
Etoposide(Dangerous)
Fluorouracil(Dangerous)
Nivolumab(Unsafe)
Doxorubicin(Dangerous)
Alemtuzumab(Low Risk)
Vinblastine(Dangerous)
Cyclophosphamide(Dangerous)
Rituximab(Low Risk)
Bleomycin(Dangerous)
Docetaxel(Dangerous)
Cisplatin(Unsafe)
Bevacizumab(Low Risk)
Vinorelbine(Dangerous)
Busulfan(Dangerous)
Pazopanib(Unsafe)
Dacarbazine(Dangerous)
Trastuzumab(Unsafe)
Imatinib(Unsafe)
Thioguanine(Dangerous)
Cladribine(Dangerous)
Letrozole(Dangerous)
Azelaic Acid(Safe)
Erlotinib(Unsafe)
Dasatinib(Unsafe)
Exemestane(Dangerous)
Vincristine(Dangerous)
Dactinomycin(Dangerous)
Nilotinib(Unsafe)
Tamoxifen(Dangerous)
Ipilimumab(Unsafe)
Mitoxantrone(Dangerous)
Letrozole(Dangerous)
Exemestane(Dangerous)